Editor in Chief

Dr. Chun Liang completed his Ph.D in Biology from Brown University. He received many awards and fellowships, the most recent being Hong Kong Scholar Postdoctoral Fellowship Supervisor Award. He published many research articles out of which 23 are highly reputed. He holds 4 patents. Currently he is working as an Associate Professor in the Division of Life Science, Center for Cancer Research,…

Name : Dr. Chun Liang
University : Hong Kong University of Science and Technology

Indexing and Listing

          

Recent Articles

PubMed Indexed Articles

  • article image

    Homeodomain Transcription Factor Msx-2 Regulates Uterine Progenitor Cell Response to Diethylstilbestrol

    The fate of mouse uterine epithelial progenitor cells is determined between postnatal days 5 to 7. Around this critical time window, exposure to an endocrine disruptor, diethylstilbestrol (DES), can profoundly alter uterine cytodifferentiation. We have shown previously that a homeo domain transcription factor MSX-2 plays an important role in DES-responsiveness…

    View more
  • article image

    Brain Uptake of Neurotherapeutics after Intranasal Delivery in Mice

    There is a growing global prevalence of neurodegenerative diseases such as Alzheimer’s disease and dementia. Current treatment for neurodegenerative diseases is limited due to the blood brain barrier’s ability to restrict the entry of therapeutics to the brain. In that context, direct delivery of drugs from nose to brain has gained emerging interest…

    View more
  • article image

    Current Studies of Immunotherapy on Glioblastoma

    Glioblastoma is a form of brain tumor with a very high morbidity and mortality. Despite decades of research, the best treatments currently in clinical practice only extend survival by a number of months. A promising alternative to conventional treatment for glioblastomas is immunotherapy. Although proposed over a century ago, the field of cancer immunotherapy…

    View more

Testimonial